Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesMRIMRI safety manual gets a makeoverEmergency situations, MRI screening, and special patients and personnel are addressed in an updated safety guide.Health EquityResolution on imaging access awaits World Health Assembly approvalUltrasoundWhat can we learn from astronauts' use of ultrasound?Womens ImagingAI speeds up fetal ultrasound scan timesCTNociceptive responses to contrast CT aren't necessarily pathology